ClinicalTrials.gg
Not yet recruitingNCT07379294Updated May 14, 2026

Soft Foam Dressings for Pressure Injury Prevention of Cardiac Surgery

An interventional study of CONVAFoam Hydrofiber Dressing and Standard Pressure Injury Prevention Care in CAD - Coronary Artery Disease, CABG and Valve Disease, Heart, sponsored by Shih,Wen-Chi. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-14.

Sponsored by Shih,Wen-Chi · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to evaluate whether the application of soft foam dressings can reduce the occurrence of surgery-related pressure injuries among patients undergoing cardiac surgery. Specifically, this research aims to investigate differences in pressure injury outcomes before and after the intervention, and to assess the preventive effectiveness of soft foam dressings as an adjunctive skin-protection strategy.

Read the detailed description

The goal of this clinical trial is to learn if applying soft foam dressings (AQUACEL Foam Hydrofiber Dressing) can prevent surgery-related pressure injuries in adult patients (≥18 years) undergoing cardiac surgery under general anesthesia with cardiopulmonary bypass (CPB). The main questions it aims to answer are:

Does the use of soft foam dressings reduce the incidence of perioperative pressure injuries compared with routine skin protection measures alone? Does the intervention delay the time to pressure injury development and improve postoperative skin integrity during the first 5 postoperative days? Researchers will compare the intervention group (routine prevention + AQUACEL Foam applied to high-risk pressure areas) to the control group (routine prevention only) to see if the foam dressing intervention reduces pressure injury occurrence after cardiac surgery.

Participants will:

Be screened for eligibility and provide written informed consent Receive either routine pressure injury prevention care alone (control group) or routine care plus AQUACEL Foam dressings (intervention group) applied to pressure-prone areas (e.g., heels, sacrococcygeal region, and hallux bony prominence) Complete a demographic questionnaire (approximately 10 minutes; self-completed or assisted by the researcher)

Undergo skin assessments 6 times:

T0: during preoperative preparation T1: immediately after surgery T2-T5: once daily for 4 consecutive days after ICU transfer Have perioperative and clinical data collected from medical records (e.g., surgical duration, CPB time/temperature, laboratory values such as albumin, Hb, RBC, Hct, BUN, creatinine)

02

Conditions studied

  • CAD - Coronary Artery Disease
  • CABG
  • Valve Disease, Heart
  • Aortic Diseases
  • Valve Heart Stenosis
  • Aortic Aneurysm
  • Mitral Disease
  • AORTIC VALVE DISEASES
  • Aortic Dissection
03

In context

Coronary Artery Disease

4,857 studies on the registry are indexed under Coronary Artery Disease; 890 are open to participants now.

This study's planned enrollment of 80 is below the median of 124 across 3,006 interventional studies indexed under Coronary Artery Disease.

Browse Coronary Artery Disease studies →

Lead sponsor

This is the only study on the registry with Shih,Wen-Chi as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years or older
  • Scheduled to undergo cardiac surgery under general anesthesia
  • Use of cardiopulmonary bypass (CPB) during surgery
  • Expected surgical duration greater than 4 hours
  • Intact skin without pre-existing pressure injury prior to surgery

Exclusion criteria

Exclusion Criteria:

  • Surgical position other than supine
  • Long-term bedridden status prior to hospital admission
  • Altered consciousness or inability to cooperate
  • History of stroke with residual limb weakness
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Prophylactic soft foam Dressing

    In addition to general routine skin protection measures, also add soft foam dressings.

    Device: CONVAFoam Hydrofiber Dressing · Other: Standard Pressure Injury Prevention Care

  • Active comparator
    Standard Pressure Injury Prevention Care

    General routine skin protection measures (fatty pressure relief pads, cotton rolls or towels to isolate tubing, heel pads, etc.)

    Other: Standard Pressure Injury Prevention Care

Interventions

  • DeviceCONVAFoam Hydrofiber Dressing

    Add prophylactic application of CONVAFoam dressing to high-risk pressure areas (heels, sacrococcygeal region, hallux prominence)

    Also known as: CONVAfoam

  • OtherStandard Pressure Injury Prevention Care

    Routine perioperative pressure injury prevention measures including pressure-relieving pads, heel pads, positioning support, and cotton/towel separation according to institutional protocol.

06

What researchers measure

Primary outcomes

  1. Incidence of surgery-related pressure injuries

    The occurrence of new pressure injuries at any anatomical site, assessed using NPIAP staging criteria. Skin assessments will be performed by trained staff at predefined perioperative time points to determine whether a pressure injury develops after surgery.

    Time frame: From preoperative baseline (before surgery) to postoperative day 5

Secondary outcomes

  1. Time to development of pressure injury

    The time (in days) from surgery completion to the first documented occurrence of a pressure injury.

    Time frame: From end of surgery to postoperative day 5

  2. Severity stage of pressure injuries

    The highest NPIAP stage of any pressure injury observed during the 5 postoperative days.

    Time frame: Postoperative day 1 to postoperative day 5

Other outcomes

  1. Cardiopulmonary Bypass Duration

    The correlation between the time from the start to the end of cardiopulmonary bypass and pressure injury was investigated, and the total time of cardiopulmonary bypass (in minutes) was measured.

    Time frame: During surgery

  2. CPB Temperature at Termination

    To investigate the correlation between core temperature (°C) at the termination of cardiopulmonary bypass and pressure injury.

    Time frame: At the time of cardiopulmonary bypass termination during surgery

  3. Lowest Cardiopulmonary Bypass Temperature

    To investigate the correlation between the temperature at which the body is cooled to its lowest point during (°C) cardiopulmonary bypass and pressure injury.

    Time frame: From initiation to termination of cardiopulmonary bypass during surgery

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07379294
Lead sponsor
Shih,Wen-Chi
Responsible party
Shih,Wen-Chi (Nurse, Fu Jen Catholic University Hospital) — Sponsor-investigator
First posted
Jan 30, 2026
Start date
May 31, 2026 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
May 30, 2027 (estimated)
Last update
May 14, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion